Anavex Life Sciences (AVXL) Sinks on 2-73 Abstract Update

Anavex Life Sciences Corp. (NASDAQ: AVXL) is down 17.8% today after an abstract was updated on new exploratory Alzheimer drug ANAVEX 2-73 (below).

The infamous Martin Shkreli‏ said the stock looks "worthless."

$AVXL looks worthless. Compound is uM for sigma receptor (meaningless affinity) and rest of muscarinic. Co. confused if its agonist or ant.

— Martin Shkreli (@MartinShkreli) November 5, 2015

You May Also Be Interested In

• Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
• Scorpion Capital says short Twist Biosciences
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'